Publication | Closed Access

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

NeurophysiologyNeuroanatomyMedicineNeuropharmacologyNeurologyNeuroscienceCentral Nervous SystemDopamineChronic TreatmentPharmacologyNeurochemistrySocial SciencesFrontal Cortex5-Ht1a Receptor Antagonist